|
|
| | Nurulimab Basic information |
| Product Name: | Nurulimab | | Synonyms: | Nurulimab;Research Grade Nurulimab(DHD17205);Research Grade Nurulimab;Nurulimab (anti-CTLA-4) | | CAS: | 2168561-20-2 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Nurulimab Structure]() |
| | Nurulimab Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Nurulimab Usage And Synthesis |
| Uses | Nurulimab (BCD-145) is an anti-cytotoxic T lymphocyte antigen-4 (anti-CTLA-4) human monoclonal antibody. Nurulimab can be can be used in research of melanoma[1]. | | References | [1] International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 34, No. 1, 2020. |
| | Nurulimab Preparation Products And Raw materials |
|